AEON — AEON Biopharma, Inc.

AEONAEON Biopharma, Inc.

AMEX · US · Healthcare · Biotechnology · aeonbiopharma.com

0.7451USD-0.65%Mkt Cap: 19.60M USDP/E: —Last update: 2026-06-01

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 st…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap19.60M USD

Enterprise Value14.97M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-39.22M USD

Revenue/Share—

Last Price0.7451 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees8

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.10

PEG—

EV/EBITDA-0.82

EV/Revenue—

P/S—

P/B-1.14

EPS (TTM)-6.52

EPS (Forward)-0.69

52W Range

0.530023% of range1.450

52W High1.450 USD

52W Low0.5300 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE71.28%

ROA-705.43%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-17.31M USD

CapEx (TTM)4.00K USD

FCF Margin—

FCF Yield-32.23%

Net Debt-3.88M USD

Net Debt/EBITDA0.21

Balance Sheet

Debt/Equity-0.65

Current Ratio0.99

Quick Ratio0.94

Book Value/Sh-0.6620 USD

Cash/Share0.2370 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:72

Split DateFeb 26, 2025

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)6.700 USD

Target Range5.000 USD – 8.400 USD

# Analysts2

Ownership

Shares Out.26.31M

Float11.73M

Insiders85.37%

Institutions7.50%

Short Interest

Short Ratio1.8d

Short % Float1.66%

Short % Out.0.88%

Shares Short231.89K

Short (prev mo.)103.23K

Technical

SMA 500.9377 (-20.5%)

SMA 2000.9546 (-21.9%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)74.64K

Avg Vol (10d)74.49K

Technical Indicators

RSI (14)38.3

MACD-0.0575

MACD Signal-0.0500

MACD Hist.-0.0075

BB Upper0.9800 USD

BB Middle0.8368 USD

BB Lower0.6935 USD

BB Width34.23%

ATR (14)0.0639 USD

Vol Ratio (20d)0.37x